Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Taha Moussa, Khalid Afzal, Joseph Cooper, Ryan Rosenberger, Karyn Gerstle, Linda Wagner-Weiner

ABSTRACT

BACKGROUND: Anti-NMDA receptor encephalitis, an autoimmune disease associated with antibodies against N-methyl-D-aspartate (NMDA) receptors, is being diagnosed more frequently, especially in children and young adults. Acute neurological and psychiatric manifestations are the common presenting symptoms. Diagnosing anti-NMDA receptor encephalitis is often challenging given the wide range of clinical presentation, and may be further complicated by its overlap of symptoms, brain MRI changes, and CSF findings with other entities affecting the brain. Even though diagnosis can be made by identifying antibodies in immune-mediated encephalitis, the diagnosis may be delayed by weeks to months. Delay in initiation of treatment with immune suppressive therapies is shown to be associated with adverse outcomes. Malignant catatonia is a severe and life-threatening state associated with anti-NMDA receptor encephalitis. It is often inadequately assessed and may not respond to immunosuppressive treatment. CASE PRESENTATION: We present a confirmed case of anti-NMDA receptor encephalitis in a 16 year old girl who had severe critical neurological and psychiatric manifestations, including malignant catatonia and autonomic instability. Our patient continued to manifest malignant catatonia despite the initiation of prompt, aggressive immune suppressive therapies, including corticosteroids, plasmapheresis, intravenous gammaglobulin and rituximab, as well as treatment with high-dose benzodiazepines. Once electroconvulsive therapy (ECT) began, she had a robust response with resolution of her catatonia. Six weeks after treatment with eight ECT cycles, she had returned to her normal baseline cognitive and motor function. CONCLUSIONS: ECT was an effective and well-tolerated therapy in our patient, and should be considered for the treatment of children with anti-NMDA receptor encephalitis whose catatonia does not respond to immunosuppression and benzodiazepines. More... »

PAGES

8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12969-019-0310-0

DOI

http://dx.doi.org/10.1186/s12969-019-0310-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112214406

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30777097


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-N-Methyl-D-Aspartate Receptor Encephalitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzodiazepines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catatonia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electroconvulsive Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Section of Pediatric Rheumatology, Department of Pediatrics, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 5044, 60637, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moussa", 
        "givenName": "Taha", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Section of Pediatric Psychiatry, Department of Psychiatry, University of Chicago Medical Center, Chicago, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Afzal", 
        "givenName": "Khalid", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Psychiatry, University of Chicago Medical Center, Chicago, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cooper", 
        "givenName": "Joseph", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Psychiatry, University of Chicago Medical Center, Chicago, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosenberger", 
        "givenName": "Ryan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Pediatrics, University of Chicago Medical Center, Chicago, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gerstle", 
        "givenName": "Karyn", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Section of Pediatric Rheumatology, Department of Pediatrics, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 5044, 60637, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner-Weiner", 
        "givenName": "Linda", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1474-4422(15)00401-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003475655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(10)70222-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006378991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cid/cir1038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009547178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mehy.2010.11.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010747155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.21050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014338785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2014.04.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017908059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0b013e3181fbf96d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020297602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0b013e3181fbf96d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020297602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0b013e3181fbf96d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020297602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0b013e3181fbf96d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020297602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.psc.2016.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024064280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/nxi.0000000000000092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036098166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/nxi.0000000000000092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036098166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jns.2014.05.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036656568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0000000000000334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037810437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0000000000000334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037810437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(12)70310-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039456194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pra.0000000000000100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040262751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pra.0000000000000100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040262751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0447.1996.tb09814.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045210999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/appi.ajp.160.3.577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063495176"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/appi.neuropsych.11070151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063501530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000000570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064352253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000000570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064352253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000000570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064352253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000002635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064353520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000002635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064353520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000002635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064353520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0000000000000436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090287294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/yct.0000000000000436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090287294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.9758/cpn.2017.15.3.210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091089138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.brs.2018.11.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110345223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.brs.2018.11.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110345223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.brs.2018.11.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110345223"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Anti-NMDA receptor encephalitis, an autoimmune disease associated with antibodies against N-methyl-D-aspartate (NMDA) receptors, is being diagnosed more frequently, especially in children and young adults. Acute neurological and psychiatric manifestations are the common presenting symptoms. Diagnosing anti-NMDA receptor encephalitis is often challenging given the wide range of clinical presentation, and may be further complicated by its overlap of symptoms, brain MRI changes, and CSF findings with other entities affecting the brain. Even though diagnosis can be made by identifying antibodies in immune-mediated encephalitis, the diagnosis may be delayed by weeks to months. Delay in initiation of treatment with immune suppressive therapies is shown to be associated with adverse outcomes. Malignant catatonia is a severe and life-threatening state associated with anti-NMDA receptor encephalitis. It is often inadequately assessed and may not respond to immunosuppressive treatment.\nCASE PRESENTATION: We present a confirmed case of anti-NMDA receptor encephalitis in a 16\u2009year old girl who had severe critical neurological and psychiatric manifestations, including malignant catatonia and autonomic instability. Our patient continued to manifest malignant catatonia despite the initiation of prompt, aggressive immune suppressive therapies, including corticosteroids, plasmapheresis, intravenous gammaglobulin and rituximab, as well as treatment with high-dose benzodiazepines. Once electroconvulsive therapy (ECT) began, she had a robust response with resolution of her catatonia. Six weeks after treatment with eight ECT cycles, she had returned to her normal baseline cognitive and motor function.\nCONCLUSIONS: ECT was an effective and well-tolerated therapy in our patient, and should be considered for the treatment of children with anti-NMDA receptor encephalitis whose catatonia does not respond to immunosuppression and benzodiazepines.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12969-019-0310-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1035460", 
        "issn": [
          "1546-0096"
        ], 
        "name": "Pediatric Rheumatology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy", 
    "pagination": "8", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3e89d674855111a4739ca6e76647b92b113b9fc4b41778819091b1d89e4ba3b6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30777097"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101248897"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12969-019-0310-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112214406"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12969-019-0310-0", 
      "https://app.dimensions.ai/details/publication/pub.1112214406"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113650_00000005.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12969-019-0310-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12969-019-0310-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12969-019-0310-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12969-019-0310-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12969-019-0310-0'


 

This table displays all metadata directly associated to this object as RDF triples.

199 TRIPLES      21 PREDICATES      59 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12969-019-0310-0 schema:about N1609da80c2e14c30b5869c721461f47a
2 N1af650d24cef4dc5b9a331a3b421649d
3 N1d92ba9c5b934c4fb7b9d4b36fc7e502
4 N21c20618ebc2441a82be81ee6fadf951
5 N4ed50edc573c495f86d4e71dec417ef1
6 Ncd3fffb24b5645cb9127462f75a3c665
7 Nd1c750c76e754a099ca18b7868907125
8 Nfd91c68b99704e3f8fd8a387f33454d1
9 Nfff09844e61b4fc18bda349393153177
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author Nb644b1d9943e4701a5dfa8809041f519
13 schema:citation https://doi.org/10.1002/ana.21050
14 https://doi.org/10.1016/j.brs.2018.11.016
15 https://doi.org/10.1016/j.jns.2014.05.032
16 https://doi.org/10.1016/j.mehy.2010.11.001
17 https://doi.org/10.1016/j.pediatrneurol.2014.04.030
18 https://doi.org/10.1016/j.psc.2016.04.004
19 https://doi.org/10.1016/s1473-3099(10)70222-x
20 https://doi.org/10.1016/s1474-4422(12)70310-1
21 https://doi.org/10.1016/s1474-4422(15)00401-9
22 https://doi.org/10.1093/cid/cir1038
23 https://doi.org/10.1097/pra.0000000000000100
24 https://doi.org/10.1097/yct.0000000000000334
25 https://doi.org/10.1097/yct.0000000000000436
26 https://doi.org/10.1097/yct.0b013e3181fbf96d
27 https://doi.org/10.1111/j.1600-0447.1996.tb09814.x
28 https://doi.org/10.1176/appi.ajp.160.3.577
29 https://doi.org/10.1176/appi.neuropsych.11070151
30 https://doi.org/10.1212/nxi.0000000000000092
31 https://doi.org/10.1212/wnl.0000000000000570
32 https://doi.org/10.1212/wnl.0000000000002635
33 https://doi.org/10.9758/cpn.2017.15.3.210
34 schema:datePublished 2019-12
35 schema:datePublishedReg 2019-12-01
36 schema:description BACKGROUND: Anti-NMDA receptor encephalitis, an autoimmune disease associated with antibodies against N-methyl-D-aspartate (NMDA) receptors, is being diagnosed more frequently, especially in children and young adults. Acute neurological and psychiatric manifestations are the common presenting symptoms. Diagnosing anti-NMDA receptor encephalitis is often challenging given the wide range of clinical presentation, and may be further complicated by its overlap of symptoms, brain MRI changes, and CSF findings with other entities affecting the brain. Even though diagnosis can be made by identifying antibodies in immune-mediated encephalitis, the diagnosis may be delayed by weeks to months. Delay in initiation of treatment with immune suppressive therapies is shown to be associated with adverse outcomes. Malignant catatonia is a severe and life-threatening state associated with anti-NMDA receptor encephalitis. It is often inadequately assessed and may not respond to immunosuppressive treatment. CASE PRESENTATION: We present a confirmed case of anti-NMDA receptor encephalitis in a 16 year old girl who had severe critical neurological and psychiatric manifestations, including malignant catatonia and autonomic instability. Our patient continued to manifest malignant catatonia despite the initiation of prompt, aggressive immune suppressive therapies, including corticosteroids, plasmapheresis, intravenous gammaglobulin and rituximab, as well as treatment with high-dose benzodiazepines. Once electroconvulsive therapy (ECT) began, she had a robust response with resolution of her catatonia. Six weeks after treatment with eight ECT cycles, she had returned to her normal baseline cognitive and motor function. CONCLUSIONS: ECT was an effective and well-tolerated therapy in our patient, and should be considered for the treatment of children with anti-NMDA receptor encephalitis whose catatonia does not respond to immunosuppression and benzodiazepines.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N1b9811fe5cf945bc8ee905fb1db2fee7
41 N7569cd84de81458fa31a089f99e0e980
42 sg:journal.1035460
43 schema:name Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy
44 schema:pagination 8
45 schema:productId N27268f70f9574bd082ffec55bb41da54
46 N4581711ef9ca45dbb390b49e674e8cf3
47 Na24b462b073c427296297bff0b4df213
48 Nb34410f1611c4c30b68469e4ba69cfd5
49 Nf0a3cee5c4434e099096484a5f423659
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112214406
51 https://doi.org/10.1186/s12969-019-0310-0
52 schema:sdDatePublished 2019-04-11T10:31
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N014ca1fb7bc74425a56ea0370796889d
55 schema:url https://link.springer.com/10.1186%2Fs12969-019-0310-0
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N014ca1fb7bc74425a56ea0370796889d schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 N12275487549a439a8e3f622a5ab75e53 rdf:first N161c7752dac14650bb54e5a8c2a8cfb6
62 rdf:rest N9f79b3fab7bb4183a157e5d75d73a71e
63 N1609da80c2e14c30b5869c721461f47a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Catatonia
65 rdf:type schema:DefinedTerm
66 N161c7752dac14650bb54e5a8c2a8cfb6 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
67 schema:familyName Rosenberger
68 schema:givenName Ryan
69 rdf:type schema:Person
70 N1af650d24cef4dc5b9a331a3b421649d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Anti-N-Methyl-D-Aspartate Receptor Encephalitis
72 rdf:type schema:DefinedTerm
73 N1b9811fe5cf945bc8ee905fb1db2fee7 schema:volumeNumber 17
74 rdf:type schema:PublicationVolume
75 N1d92ba9c5b934c4fb7b9d4b36fc7e502 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Immunosuppressive Agents
77 rdf:type schema:DefinedTerm
78 N21c20618ebc2441a82be81ee6fadf951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Adolescent
80 rdf:type schema:DefinedTerm
81 N27268f70f9574bd082ffec55bb41da54 schema:name pubmed_id
82 schema:value 30777097
83 rdf:type schema:PropertyValue
84 N3b6848b6c13b481e906c70badf0b0818 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
85 schema:familyName Moussa
86 schema:givenName Taha
87 rdf:type schema:Person
88 N4581711ef9ca45dbb390b49e674e8cf3 schema:name doi
89 schema:value 10.1186/s12969-019-0310-0
90 rdf:type schema:PropertyValue
91 N4902ac0e7f544ac7ba5fcdc04fdd4a80 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
92 schema:familyName Cooper
93 schema:givenName Joseph
94 rdf:type schema:Person
95 N4ed50edc573c495f86d4e71dec417ef1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Electroconvulsive Therapy
97 rdf:type schema:DefinedTerm
98 N6c1e39dfe1214dad9af15433e51f1c91 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
99 schema:familyName Afzal
100 schema:givenName Khalid
101 rdf:type schema:Person
102 N6c3ddae0967241f1a9e159e6a1efa294 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
103 schema:familyName Gerstle
104 schema:givenName Karyn
105 rdf:type schema:Person
106 N7569cd84de81458fa31a089f99e0e980 schema:issueNumber 1
107 rdf:type schema:PublicationIssue
108 N9f79b3fab7bb4183a157e5d75d73a71e rdf:first N6c3ddae0967241f1a9e159e6a1efa294
109 rdf:rest Nd9dd68c7d6644750bbd0f6bdc575ff1a
110 Na24b462b073c427296297bff0b4df213 schema:name readcube_id
111 schema:value 3e89d674855111a4739ca6e76647b92b113b9fc4b41778819091b1d89e4ba3b6
112 rdf:type schema:PropertyValue
113 Na84eaae8a44549418675ddde59b71071 rdf:first N4902ac0e7f544ac7ba5fcdc04fdd4a80
114 rdf:rest N12275487549a439a8e3f622a5ab75e53
115 Nb34410f1611c4c30b68469e4ba69cfd5 schema:name dimensions_id
116 schema:value pub.1112214406
117 rdf:type schema:PropertyValue
118 Nb3b7453161f649d39edf600911569dc4 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
119 schema:familyName Wagner-Weiner
120 schema:givenName Linda
121 rdf:type schema:Person
122 Nb644b1d9943e4701a5dfa8809041f519 rdf:first N3b6848b6c13b481e906c70badf0b0818
123 rdf:rest Ndcccc53453b14246b5ca800a554c3203
124 Ncd3fffb24b5645cb9127462f75a3c665 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Benzodiazepines
126 rdf:type schema:DefinedTerm
127 Nd1c750c76e754a099ca18b7868907125 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 Nd9dd68c7d6644750bbd0f6bdc575ff1a rdf:first Nb3b7453161f649d39edf600911569dc4
131 rdf:rest rdf:nil
132 Ndcccc53453b14246b5ca800a554c3203 rdf:first N6c1e39dfe1214dad9af15433e51f1c91
133 rdf:rest Na84eaae8a44549418675ddde59b71071
134 Nf0a3cee5c4434e099096484a5f423659 schema:name nlm_unique_id
135 schema:value 101248897
136 rdf:type schema:PropertyValue
137 Nfd91c68b99704e3f8fd8a387f33454d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Humans
139 rdf:type schema:DefinedTerm
140 Nfff09844e61b4fc18bda349393153177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Female
142 rdf:type schema:DefinedTerm
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
147 schema:name Clinical Sciences
148 rdf:type schema:DefinedTerm
149 sg:journal.1035460 schema:issn 1546-0096
150 schema:name Pediatric Rheumatology
151 rdf:type schema:Periodical
152 https://doi.org/10.1002/ana.21050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014338785
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.brs.2018.11.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110345223
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.jns.2014.05.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036656568
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/j.mehy.2010.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010747155
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/j.pediatrneurol.2014.04.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017908059
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/j.psc.2016.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024064280
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/s1473-3099(10)70222-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006378991
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s1474-4422(12)70310-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039456194
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s1474-4422(15)00401-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003475655
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1093/cid/cir1038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009547178
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1097/pra.0000000000000100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040262751
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1097/yct.0000000000000334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037810437
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1097/yct.0000000000000436 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090287294
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1097/yct.0b013e3181fbf96d schema:sameAs https://app.dimensions.ai/details/publication/pub.1020297602
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1111/j.1600-0447.1996.tb09814.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045210999
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1176/appi.ajp.160.3.577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063495176
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1176/appi.neuropsych.11070151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063501530
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1212/nxi.0000000000000092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036098166
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1212/wnl.0000000000000570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064352253
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1212/wnl.0000000000002635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064353520
191 rdf:type schema:CreativeWork
192 https://doi.org/10.9758/cpn.2017.15.3.210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091089138
193 rdf:type schema:CreativeWork
194 https://www.grid.ac/institutes/grid.412578.d schema:alternateName University of Chicago Medical Center
195 schema:name Department of Pediatrics, University of Chicago Medical Center, Chicago, USA
196 Department of Psychiatry, University of Chicago Medical Center, Chicago, USA
197 Section of Pediatric Psychiatry, Department of Psychiatry, University of Chicago Medical Center, Chicago, USA
198 Section of Pediatric Rheumatology, Department of Pediatrics, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 5044, 60637, Chicago, IL, USA
199 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...